Soleno Therapeutics Income Statement (2013-2019) | SLNO

Income Statement Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019
Revenue & cost
Revenue -0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Cost of Revenue 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Gross Profit 0.00B0.00B0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.00B-0.00B
Operating items
Research & Development 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Selling, General & Administrative 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Operating Expenses 0.00B0.00B0.00B-0.00B251.00-0.00B0.00B0.00B
Operating Expenses 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B
Operating Income -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B
EBIT -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B
Non-operating items
Interest & Investment Income 772.0085.000.00B0.00B0.00B
Other Non Operating Income -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B-0.00B0.00B0.00B
Non Operating Income -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B0.00B-0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B-0.00B0.00B-0.00B
Net income details
EBT -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B
Profit After Tax -0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Income from Continuing Operations -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B
Consolidated Net Income -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Income towards Parent Company -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Preferred Dividend Payments 0.00B172.00
Net Income towards Common Stockholders -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B
Additional items
EPS (Basic) -2.97-1.62-1.56-5.21-4.47-3.28-1.670.25-0.33-0.30-220.00-0.23-0.87-1.99-0.57-0.42-0.39-0.40
EPS (Weighted Average and Diluted) -5.210.25-0.07
Shares Outstanding (Weighted Average) 0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B14.80B0.02B0.00B0.00B0.01B0.01B0.01B0.01B0.02B0.02B0.02B0.02B0.03B0.03B
Shares Outstanding (Diluted Average) 0.00B0.01B0.02B
EBITDA -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B
Interest Expenses 0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B